Literature DB >> 25256084

Chlamydia trachomatis infection is related to premature ejaculation in chronic prostatitis patients: results from a cross-sectional study.

Tommaso Cai1, Francesca Pisano, Vittorio Magri, Paolo Verze, Nicola Mondaini, Carolina D'Elia, Gianni Malossini, Sandra Mazzoli, Gianpaolo Perletti, Paolo Gontero, Vincenzo Mirone, Riccardo Bartoletti.   

Abstract

INTRODUCTION: Chronic bacterial prostatitis (CBP) is reported to be a common finding in men with acquired premature ejaculation (PE). The impact of different pathogens on PE development in chronic prostatitis patients is, however, unknown. AIM: To assess a possible link between CBP caused by Chlamydia trachomatis (Ct) and PE.
METHODS: A consecutive series of 317 patients with clinical and instrumental diagnosis of CBP due to Ct was enrolled (group A) and compared with data obtained from a control group of 639 patients with CBP caused by common uropathogen bacteria (group B). Prostatitis symptoms were investigated with the National Institutes of Health-Chronic Prostatitis Symptom Index (NIH-CPSI), while the ejaculatory status of patients was assessed using the PE Diagnostic Tool (PEDT). MAIN OUTCOME MEASURES: All participants were asked to complete the NIH-CPSI, the International Index of Erectile Function-15 erectile function domain (IIEF-15-EFD), the PEDT, and the Short Form (SF)-36 questionnaires.
RESULTS: Patient groups A and B had comparable scores of NIH-CPSI (P = 0.07), IPSS (P = 0.32), and IIEF-15-EFD (P = 0.33) tests. PE was assessed in 118 patients in group A (37.2%) and in 73 subjects in group B (11.5%). The two groups are different in terms of PE prevalence (P < 0.0002). Compared with group B, group A showed significantly higher scores of the PEDT test (11.3 [±2.6] vs. 4.5 [±2.9], P < 0.0001) and lower scores of the SF-36 tool (96.5 [±1.1] vs. 99.7 [±1.3], P < 0.0001). In our multivariate model assessment, being positive for a Ct infection marker was independently associated with the PEDT score even after adjusting for age, smoking habit, body mass index, and education level (adjusted odds ratio = 3.21; 95% confidence interval: 2.02-4.27; P < 0.003).
CONCLUSIONS: Patients affected by CBP due to Ct infection reported higher prevalence of PE and lower quality of life when compared with patients affected by CBP caused by traditional uropathogenic bacteria.
© 2014 International Society for Sexual Medicine.

Entities:  

Keywords:  Acquired Early Ejaculation; Chlamydia trachomatis; NIH-CPSI; PEDT; Premature Ejaculation; Quality of Life

Mesh:

Substances:

Year:  2014        PMID: 25256084     DOI: 10.1111/jsm.12699

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  5 in total

1.  Chlamydia trachomatis versus common uropathogens as a cause of chronic bacterial prostatitis: Is there any difference? Results of a prospective parallel-cohort study.

Authors:  Tommaso Cai; Francesca Pisano; Gabriella Nesi; Vittorio Magri; Paolo Verze; Gianpaolo Perletti; Paolo Gontero; Vincenzo Mirone; Riccardo Bartoletti
Journal:  Investig Clin Urol       Date:  2017-10-31

Review 2.  Current Knowledge of the Potential Links between Inflammation and Prostate Cancer.

Authors:  Tommaso Cai; Raffaella Santi; Irene Tamanini; Ilaria Camilla Galli; Gianpaolo Perletti; Truls E Bjerklund Johansen; Gabriella Nesi
Journal:  Int J Mol Sci       Date:  2019-08-06       Impact factor: 5.923

Review 3.  Pharmacological Interventions for Bacterial Prostatitis.

Authors:  Situ Xiong; Xiaoqiang Liu; Wen Deng; Zhengtao Zhou; Yulei Li; Yechao Tu; Luyao Chen; Gongxian Wang; Bin Fu
Journal:  Front Pharmacol       Date:  2020-04-30       Impact factor: 5.810

4.  Prevalence of sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome: a meta-analysis.

Authors:  Hong-Jun Li; De-Ying Kang
Journal:  World J Urol       Date:  2015-11-06       Impact factor: 4.226

5.  Rhodiola rosea, folic acid, zinc and biotin (EndEP®) is able to improve ejaculatory control in patients affected by lifelong premature ejaculation: Results from a phase I-II study.

Authors:  Tommaso Cai; Paolo Verze; Paolo Massenio; Daniele Tiscione; Gianni Malossini; Luigi Cormio; Giuseppe Carrieri; Vincenzo Mirone
Journal:  Exp Ther Med       Date:  2016-08-12       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.